Market closed
Anteris Technologies Global/$AVR
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Anteris Technologies Global
Anteris Technologies Global Corp. is a structural heart company committed to discovering, developing and commercializing medical devices designed to improve the quality of life for patients with aortic stenosis. Its product, the DurAVR THV system, represents a product opportunity in a new THV class of single-piece heart valves, for the treatment of aortic stenosis. Its DurAVR THV system consists of a single-piece, biomimetic valve made with its proprietary ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold.
Ticker
$AVR
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Toowong, Australia
Employees
136
Website
AVR Metrics
BasicAdvanced
$132M
-
-$3.77
0.65
-
Price and volume
Market cap
$132M
Beta
0.65
52-week high
$8.36
52-week low
$3.05
Financial strength
Current ratio
4.508
Quick ratio
4.438
Long term debt to equity
1.029
Total debt to equity
2.226
Interest coverage (TTM)
-153.07%
Management effectiveness
Return on assets (TTM)
-88.08%
Return on equity (TTM)
-186.24%
Valuation
Price to revenue (TTM)
24.689
Price to book
3.38
Price to tangible book (TTM)
3.39
Price to free cash flow (TTM)
-1.051
Growth
Revenue change (TTM)
-1.17%
Earnings per share change (TTM)
27.73%
3-year revenue growth (CAGR)
-17.54%
3-year earnings per share growth (CAGR)
25.37%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Anteris Technologies Global stock?
Anteris Technologies Global (AVR) has a market cap of $132M as of April 05, 2025.
What is the P/E ratio for Anteris Technologies Global stock?
The price to earnings (P/E) ratio for Anteris Technologies Global (AVR) stock is 0 as of April 05, 2025.
Does Anteris Technologies Global stock pay dividends?
No, Anteris Technologies Global (AVR) stock does not pay dividends to its shareholders as of April 05, 2025.
When is the next Anteris Technologies Global dividend payment date?
Anteris Technologies Global (AVR) stock does not pay dividends to its shareholders.
What is the beta indicator for Anteris Technologies Global?
Anteris Technologies Global (AVR) has a beta rating of 0.65. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.